Search

Your search keyword '"Marcelin, Anne-Geneviève"' showing total 1,149 results

Search Constraints

Start Over You searched for: Author "Marcelin, Anne-Geneviève" Remove constraint Author: "Marcelin, Anne-Geneviève"
1,149 results on '"Marcelin, Anne-Geneviève"'

Search Results

1. Early phylodynamics analysis of the COVID-19 epidemic in France

2. SARS-CoV-2 genomic surveillance and reliability of PCR single point mutation assay (SNPsig® SARS-CoV-2 EscapePLEX CE) for the rapid detection of variants of concern in Cameroon

4. Novel scores relevant to antimicrobial resistance and hospital-acquired infections developed with data from a multi-hospital consortium in the Parisian region of France

5. Viral loads in clinical samples of men with monkeypox virus infection: a French case series

6. The RT M184V resistance mutation clearance in the reservoir is mainly related to CD4 nadir and viral load zenith independently of therapeutic regimen type

7. Ultra-rapid selection of the N74D capsid inhibitor resistance mutation after 3 weeks on lenacapavir

8. Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19

9. Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES study

12. Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in Adults

13. Cumulative incidence of SARS-CoV-2 infection and associated risk factors among frontline health care workers in Paris: the SEROCOV cohort study

15. Similar Viral and Immune Characteristics of Kaposi Sarcoma in ART-treated People Living With HIV and Older Patients With Classic Kaposi Sarcoma.

16. Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients

17. Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

18. Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART

19. Use of genotypic HIV DNA testing: a DELPHI-type consensus

20. Seroprevalence of Crimean-Congo hemorrhagic fever virus among people living with HIV in Brazzaville, Congo and among blood donors in Bamako, Mali

21. Prevalence of cervical HPV infection, sexually transmitted infections and associated antimicrobial resistance in women attending cervical cancer screening in Mali

22. SARS-CoV-2 infection in patients with primary central nervous system lymphoma

25. Spike Protein Genetic Evolution in Patients at High Risk of Severe Coronavirus Disease 2019 Treated by Monoclonal Antibodies.

27. Higher levels of SARS-CoV-2 genetic variation in immunocompromised patients: a retrospective case-control study

28. Comparative Performance of Anyplex II HPV28 and Cobas 4800 Human Papillomavirus (HPV) Assays for High-Risk HPV Detection in Self-collected Anal Samples

29. Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients

32. Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma.

35. Is vaccine response to SARS-CoV-2 preserved after switching to anti-CD20 therapies in patients with multiple sclerosis or related disorders?

36. Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

37. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial

39. Extending vaccination periods against human papillomavirus: Lessons from the SARS‐CoV‐2 pandemic.

42. Identification of natural killer markers associated with fatal outcome in COVID-19 patients

43. Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals

44. Prevalence and risk factors of anal human papillomavirus infections among men having sex with men and transgender women in Phnom Penh, Cambodia

45. High rate of Early HEV Seroconversion after Liver Transplantation among Cirrhotic Patients: Should We Test for it?

47. Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants

48. Phylodynamics of SARS-CoV-2 in France, Europe and the world in 2020

49. SARS-CoV-2 variant-dependent inflammasome activation

Catalog

Books, media, physical & digital resources